Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study

BACKGROUND: Tofacitinib is a small molecule that inhibits Janus kinase and has been reported to be effective in Western patients with ulcerative colitis (UC). However, the real-life data on tofacitinib in Asian UC patients are limited. OBJECTIVE: To investigate the real-life effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung Hwan, Oh, Kyunghwan, Hong, Sung Noh, Lee, Jungbok, Oh, Shin Ju, Kim, Eun Soo, Na, Soo-Young, Kang, Sang-Bum, Koh, Seong-Joon, Bang, Ki Bae, Jung, Sung-Ae, Jung, Sung Hoon, Kim, Kyeong Ok, Park, Sang Hyoung, Yang, Suk-Kyun, Choi, Chang Hwan, Ye, Byong Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026122/
https://www.ncbi.nlm.nih.gov/pubmed/36950251
http://dx.doi.org/10.1177/17562848231154103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026122/
https://www.ncbi.nlm.nih.gov/pubmed/36950251
http://dx.doi.org/10.1177/17562848231154103

Ejemplares similares